Esposito, Giuseppe

Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation. [electronic resource] - Gut Aug 2014 - 1300-12 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1468-3288

10.1136/gutjnl-2013-305005 doi


Amides
Anilides--pharmacology
Animals
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Cells, Cultured
Colitis--chemically induced
Colitis, Ulcerative--drug therapy
Colon, Sigmoid--chemistry
Cyclooxygenase 2--metabolism
Dextran Sulfate
Dinoprostone--metabolism
Endocannabinoids--pharmacology
Ethanolamines--pharmacology
Female
Glial Fibrillary Acidic Protein--metabolism
Humans
Indoles--pharmacology
Male
Mice
Middle Aged
NF-kappa B--metabolism
Nerve Tissue Proteins--metabolism
Neuroglia--drug effects
Neutrophil Infiltration--drug effects
Nitric Oxide--analysis
Nitric Oxide Synthase Type II--metabolism
PPAR alpha--antagonists & inhibitors
PPAR gamma--antagonists & inhibitors
Palmitic Acids--pharmacology
Rectum--chemistry
S100 Calcium Binding Protein beta Subunit--metabolism
Severity of Illness Index
Signal Transduction
Toll-Like Receptor 4--metabolism
Tumor Necrosis Factor-alpha--metabolism